Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction vs Concurrent Chemoradiotherapy for Stage III NSCLC
NCT00003387Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jul 1998
- Primary completion
- May 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin, paclitaxel in non-small cell lung cancer (NSCLC), sponsored by Cancer and Leukemia Group B. Started Jul 1998; status: completed.
02
Drugs
carboplatinpaclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00003387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003387.